Cilostazol - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for cilostazol and what is the scope of freedom to operate?

Cilostazol is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Apotex Inc, Aurobindo Pharma Usa, Chartwell Rx, Epic Pharma Llc, Hikma, Ivax Sub Teva Pharms, Nostrum Labs Inc, Pliva Hrvatska Doo, Rising, Slate Run Pharma, Teva, and Otsuka, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cilostazol. Nine suppliers are listed for this compound.

Sponsor	Phase
NeuroDawn Pharmaceutical Co., Ltd.	Phase 2
Beijing Tiantan Hospital	Phase 2
Misr International University	Phase 2/Phase 3

Sponsor

Phase

NeuroDawn Pharmaceutical Co., Ltd.

Phase 2

Beijing Tiantan Hospital

Phase 2

Misr International University

Phase 2/Phase 3

US Patents and Regulatory Information for cilostazol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Epic Pharma Llc	CILOSTAZOL	cilostazol	TABLET;ORAL	077022-002	Mar 11, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	CILOSTAZOL	cilostazol	TABLET;ORAL	077831-001	Sep 24, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	CILOSTAZOL	cilostazol	TABLET;ORAL	077310-001	Nov 8, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	CILOSTAZOL	cilostazol	TABLET;ORAL	077021-001	Nov 23, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apotex Inc	CILOSTAZOL	cilostazol	TABLET;ORAL	077030-001	Dec 10, 2004	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Otsuka	PLETAL	cilostazol	TABLET;ORAL	020863-001	Jan 15, 1999	⤷ Sign Up	⤷ Sign Up
Otsuka	PLETAL	cilostazol	TABLET;ORAL	020863-002	Jan 15, 1999	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

TABLET;ORAL

Jan 15, 1999

⤷ Sign Up

TABLET;ORAL

Jan 15, 1999

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	13
NDAs:	15
Drug Master File Entries:	12
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	128
Clinical Trials:	136
Patent Applications:	6,739
Drug Prices:	Drug price trends for cilostazol
What excipients (inactive ingredients) are in cilostazol?	cilostazol excipients list
DailyMed Link:	cilostazol at DailyMed

Drug Class	Phosphodiesterase 3 Inhibitor
Mechanism of Action	Phosphodiesterase 3 Inhibitors

Cilostazol - Generic Drug Details

What are the generic sources for cilostazol and what is the scope of freedom to operate?

Summary for cilostazol

Recent Clinical Trials for cilostazol

Pharmacology for cilostazol

Anatomical Therapeutic Chemical (ATC) Classes for cilostazol

US Patents and Regulatory Information for cilostazol

Expired US Patents for cilostazol

Make Better Decisions: Try a trial or see plans & pricing